RJ Hamster
📈 Investor’s Insight: Dive into the Stock Report for…
Did the government just make a $500 trillion mistake? (Ad)
See the full briefing and how it works ▷
STOCK OF THE DAY
Medline (NASDAQ:MDLN)
CURRENT PRICE
$46.00+0.04 (+0.09%)(As of 01/23/2026 04:00 PM ET)30 DAY PERFORMANCE +4.24%
MARKET CAPITALIZATION
$60.43B
PRICE TARGET
$47.42
ABOUT MEDLINE
Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers. In addition to product manufacturing and… Read Full Profile ▷
MDLN COMPANY CALENDAR
JAN 25, 2026TodayDEC 31, 2026Fiscal Year End
RECENT MEDLINE NEWS
FRI. JANUARY 23, 2026 7:49 PM EST | MSN.COM
Medline sees RS rating climb to 77THU. JANUARY 22, 2026 7:10 PM EST | MARKETBEAT.COM
Medline (NASDAQ:MDLN) Reaches New 1-Year High – Still a Buy?THU. JANUARY 22, 2026 12:20 PM EST | FINANCE.YAHOO.COM
Medline price target raised to $55 from $50 at BTIGTHU. JANUARY 22, 2026 12:20 PM EST | MSN.COM
Jim Cramer says Medline stock is unbelievable and recommends buying itTHU. JANUARY 22, 2026 7:19 AM EST | FINANCE.YAHOO.COM
Jim Cramer Says Medline “Stock Is Unbelievable” And Recommends Buying It
Top Stock News for Sunday, January 25th
Best $19 you’ll spend this year. (Ad)
A former hedge fund manager known for cutting through market noise is briefly opening access to his flagship trading strategy. In a short demo, he explains how his “One Ticker” approach works — and how readers can access the full service for a year at a steep discount.Watch the brief demo here ▷
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors
Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional biotech riskRead The Full Story ▷
Procter & Gamble Confirms a Bottom—Time to Start Compounding?
Procter & Gamble is well-positioned to deliver market-beating total returns over time as its stock price recovers from long-term lows and dividends grow.Read The Full Story ▷
Why insiders are whispering “$24,000 gold” (Ad)
Some analysts are revisiting historical monetary resets and the role gold has played when governments faced large debt imbalances.
A new free report examines how gold was previously revalued to support national balance sheets, why recent comments from policymakers and investors have renewed interest in this topic, and what individuals may want to understand about protecting long-term savings during periods of monetary change.Download the free report here ▷
The Hot Dog Hedge: Smithfield Acquires Nathan’s Famous
Smithfield Foods leverages its cash reserves to acquire Nathan’s Famous in a strategic move that secures brand ownership and eliminates future royalty fees.Read The Full Story ▷
What’s the Best Way to Buy Gold in 2026?
Gold prices are near record highs in 2026; investors can choose between gold ETFs and mining stocks based on risk tolerance, liquidity, and return potentialRead The Full Story ▷
The Fed just flipped the switch for crypto (Ad)
The Fed just flipped the switch for crypto
The biggest wealth transfer in crypto history about to begin.Click here to see more ▷
Is Abbott’s January Pullback a Good Time to Buy?
Abbott Laboratories’ January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its business and driving cash flow.Read The Full Story ▷
MarketBeat Media, LLC dba StockReport.com
345 N Reid Place, Suite 620
Sioux Falls, SD 57103.
contact@stockreport.comUnsubscribe ▷
